C4 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
February 27, 2025 07:00 ET | Source: C4 Therapeutics, Inc. Planning Activities…
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 20TH + WALMART REPORTS EARNINGS
NEW YORK, Feb. 20, 2025 /PRNewswire/ -- The New York Stock Exchange…
Global Semiconductor Manufacturing Industry Reports Solid Q4 2024 Results, SEMI Reports
MILPITAS, Calif., Feb. 18, 2025 /PRNewswire/ -- The global semiconductor manufacturing industry closed…
TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant
TAIPEI, Feb. 17, 2025 /PRNewswire/ -- TAHO Pharmaceuticals announces positive preliminary results…
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a…
Calian Reports on the Election of Directors Voting Results
OTTAWA, Ontario, Feb. 14, 2025 (GLOBE NEWSWIRE) -- The following matter was…
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025
Received overwhelming shareholder support in favour of take-private transaction with Aditxt Advanced…
Aeries Technology, Inc. Reports Results for Third Fiscal Quarter 2025
North America Revenue Up 13.1% Year-Over-Year. Core adjusted EBITDA for the third…
Synaptics Reports Inducement Grants Following Completion of Broadcom Agreement
SAN JOSE, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq:…
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 13, 2025 16:05 ET | Source: Vera Therapeutics BRISBANE, Calif., Feb.…